The 27th Annual Great Lakes Biomedical Conference
Friday April 4, 2003
Golden Rondelle Theatre
SC Johnson Wax
Racine, Wisconsin
Program :
Nanotechnology is a powerful new tool that can sense, measure and
control events in molecular dimensions. This provides
never-before available access to a wide range of molecular applications
in physics, chemistry and biology. What does this mean to you?
Innovation is a natural part
of nanotechnology and these frontiers offer many new opportunities in
business, research and education for both professionals and
students. This conference will cover the principles of
nanotechnology and applications in transistors, biosensors and early
detection of viral agents such as West Nile Virus.
INVITED SPEAKERS :
Dr. Wolfgang Porod: currently is Frank M. Freimann
Professor of Electrical Engineering at the University of Notre Dame. He
received his Diplom (M.S.) and Ph.D. degrees from the University of
Graz, Austria, in 1979 and 1981, respectively. After appointments as a
postdoctoral fellow at
Colorado State University and as a senior research analyst at Arizona
State
University, he joined the University of Notre Dame in 1986 as an
Associate Professor. He now also serves as the Director of Notre Dame’s
Center for Nano
Science and Technology. His research interests are in the area of
nanoelectronics,
with an emphasis on new circuit concepts for novel devices. He has
authored
some 300 publications and presentations.
He is a Fellow of the IEEE and he currently serves as the Vice
President for Publications on the newly-created IEEE Nanotechnology
Council. He also has been appointed an Associate Editor for the new
IEEE Transactions on Nanotechnology. He is a Founding Member of the
IEEE Circuits and Systems Society’s Technical Committee on
Nanoelectronics and Gigascale Systems, and he has been active in
organizing Special Sessions and Tutorials, and as a speaker in the CAS
Distinguished Lecturer Program.
Dr. Barbara Israel: is a Founder and is Chief
Operating Officer
of Platypus Technologies, LLC. She also holds an appointment as a
Senior
Scientist in the School of Veterinary Medicine, University of
Wisconsin-Madison.
She received her PhD in Medical Microbiology from the University of
Vermont
and did her post doctoral training in virology at the University of
Wisconsin-Madison.
She has conducted research on arboviruses for the past 15 years with
interests
in viral pathogenesis and viral evolution. For the past 4 years,
she
has been engaged in the application of nanotechnology to the life
sciences,
particulary for the rapid detection of molecular interactions.
Dr. Israel received her PhD in medical microbiology from the School
of Medicine, University of Vermont, Burlington, Vermont. She completed
postdoctoral training in virology at the University of
Wisconsin-Madison. She holds an appointment in the Department of
Pathobiological Sciences, School of Veterinary Medicine, University of
Wisconsin-Madison where she has conducted research on animal and human
viruses for 18 years. Her professional interests are in the areas of
viral pathogenesis, viral evolution, emerging viral diseases, viral
diagnostics and nanotechnology.
In 2000, Dr. Israel co-founded Platypus Technologies, Madison WI and
serves as the Chief Operating Officer. The mission of the company is to
apply nanotechnologies to the life sciences. Platypus is developing a
broad platform technology that combines nanostructured surfaces with
liquid crystals to detect molecular interactions. The technology has
application to drug discovery, infectious disease diagnostics, sensor
technology, environmental monitoring and proteomics. The Company
currently has 18 employees and has received 7 Small Business Innovative
Research Awards totaling approximately $4.0 million.